The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

CITY THERAPEUTICS, INC. insider acquisitions

Company CIK 0002143850 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
CTY · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 22, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
30-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Stock awardCode AStock Option (Right to Buy)Derivative · Currency not specified6Not applicable0
ConversionCode CCommon StockNon-derivative · Currency not specified7Not applicable7
PurchaseCode PCommon StockNon-derivative · Currency not specified26,120,0000

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.CRANDELL KEITHCRANDELL KEITHGILLIS STEVENGILLIS STEVENBurow KristinaBurow KristinaARCH Venture Fund XII, L.P.ARCH Venture Fund XII, L.P.ARCH Venture Partners XII, LLCARCH Venture Partners XII…ARCH Venture Partners XII, L.P.ARCH Venture Partners XII…NELSEN ROBERTNELSEN ROBERTMARAGANORE JOHNMARAGANORE JOHNCRANDELL KEITH · October 19, 2026 · Purchase · Common StockGILLIS STEVEN · October 19, 2026 · Purchase · Common StockBurow Kristina · October 19, 2026 · Purchase · Common StockARCH Venture Fund XII, L.P. · October 19, 2026 · Purchase · Common StockARCH Venture Partners XII, LLC · October 19, 2026 · Purchase · Common StockARCH Venture Partners XII, L.P. · October 19, 2026 · Purchase · Common StockCRANDELL KEITH · October 19, 2026 · Conversion · Common StockGILLIS STEVEN · October 19, 2026 · Conversion · Common StockBurow Kristina · October 19, 2026 · Conversion · Common StockARCH Venture Fund XII, L.P. · October 19, 2026 · Conversion · Common StockARCH Venture Partners XII, LLC · October 19, 2026 · Conversion · Common StockARCH Venture Partners XII, L.P. · October 19, 2026 · Conversion · Common StockCRANDELL KEITH · October 19, 2026 · Conversion · Common StockGILLIS STEVEN · October 19, 2026 · Conversion · Common StockBurow Kristina · October 19, 2026 · Conversion · Common StockARCH Venture Fund XII, L.P. · October 19, 2026 · Conversion · Common StockARCH Venture Partners XII, LLC · October 19, 2026 · Conversion · Common StockARCH Venture Partners XII, L.P. · October 19, 2026 · Conversion · Common StockCRANDELL KEITH · October 19, 2026 · Conversion · Common StockGILLIS STEVEN · October 19, 2026 · Conversion · Common StockBurow Kristina · October 19, 2026 · Conversion · Common StockARCH Venture Fund XII, L.P. · October 19, 2026 · Conversion · Common StockARCH Venture Partners XII, LLC · October 19, 2026 · Conversion · Common StockARCH Venture Partners XII, L.P. · October 19, 2026 · Conversion · Common StockNELSEN ROBERT · October 15, 2026 · Stock award · Stock Option (Right to Buy)NELSEN ROBERT · October 19, 2026 · Purchase · Common StockNELSEN ROBERT · October 19, 2026 · Conversion · Common StockNELSEN ROBERT · October 19, 2026 · Conversion · Common StockNELSEN ROBERT · October 19, 2026 · Conversion · Common StockMARAGANORE JOHN · October 15, 2026 · Stock award · Stock Option (Right to Buy)MARAGANORE JOHN · October 19, 2026 · Conversion · Common StockOct 15, 2026Oct 19, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

15 dated transactions · 8 of 12 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockCRANDELL KEITH · GILLIS STEVEN · Burow Kristina · ARCH Venture Fund XII, L.P. · ARCH Venture Partners XII, LLC · ARCH Venture Partners XII, L.P.Purchase
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockCRANDELL KEITH · GILLIS STEVEN · Burow Kristina · ARCH Venture Fund XII, L.P. · ARCH Venture Partners XII, LLC · ARCH Venture Partners XII, L.P.Conversion
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockCRANDELL KEITH · GILLIS STEVEN · Burow Kristina · ARCH Venture Fund XII, L.P. · ARCH Venture Partners XII, LLC · ARCH Venture Partners XII, L.P.Conversion
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockCRANDELL KEITH · GILLIS STEVEN · Burow Kristina · ARCH Venture Fund XII, L.P. · ARCH Venture Partners XII, LLC · ARCH Venture Partners XII, L.P.Conversion
Oct 15, 2026CITY THERAPEUTICS, INC.Stock Option (Right to Buy)NELSEN ROBERTStock award
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockNELSEN ROBERTPurchase
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockNELSEN ROBERTConversion
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockNELSEN ROBERTConversion
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockNELSEN ROBERTConversion
Oct 15, 2026CITY THERAPEUTICS, INC.Stock Option (Right to Buy)MARAGANORE JOHNStock award
Oct 19, 2026CITY THERAPEUTICS, INC.Common StockMARAGANORE JOHNConversion
Oct 15, 2026CITY THERAPEUTICS, INC.Stock Option (Right to Buy)Nochur SaraStock award
Oct 19, 2026CITY THERAPEUTICS, INC.Stock Option (Right to Buy)ORTH ANDREW C.Stock award
Oct 15, 2026CITY THERAPEUTICS, INC.Stock Option (Right to Buy)Philip Ron MStock award
Oct 15, 2026CITY THERAPEUTICS, INC.Stock Option (Right to Buy)Greene Barry EStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

CTY · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
GILLIS STEVEN10% owner
Burow Kristina10% owner
ARCH Venture Fund XII, L.P.10% owner
ARCH Venture Partners XII, LLC10% owner
ARCH Venture Partners XII, L.P.10% owner
Joint filing · amounts unallocated		PurchaseCommon StockNon-derivative security · Code P170,00018Value: 3,060,000Currency not specifiedView ↗
Trade:
GILLIS STEVEN10% owner
Burow Kristina10% owner
ARCH Venture Fund XII, L.P.10% owner
ARCH Venture Partners XII, LLC10% owner
ARCH Venture Partners XII, L.P.10% owner
Joint filing · amounts unallocated		ConversionCommon StockNon-derivative security · Code C2,027,006Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
GILLIS STEVEN10% owner
Burow Kristina10% owner
ARCH Venture Fund XII, L.P.10% owner
ARCH Venture Partners XII, LLC10% owner
ARCH Venture Partners XII, L.P.10% owner
Joint filing · amounts unallocated		ConversionCommon StockNon-derivative security · Code C5,482,309Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
GILLIS STEVEN10% owner
Burow Kristina10% owner
ARCH Venture Fund XII, L.P.10% owner
ARCH Venture Partners XII, LLC10% owner
ARCH Venture Partners XII, L.P.10% owner
Joint filing · amounts unallocated		ConversionCommon StockNon-derivative security · Code C3,294,900Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
NELSEN ROBERTDirector · 10% owner
Stock awardStock Option (Right to Buy)Derivative security · Code A22,6490Value: 0Currency not specifiedView ↗
Trade:
NELSEN ROBERTDirector · 10% owner
PurchaseCommon StockNon-derivative security · Code P170,00018Value: 3,060,000Currency not specifiedView ↗
Trade:
NELSEN ROBERTDirector · 10% owner
ConversionCommon StockNon-derivative security · Code C2,027,006Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
NELSEN ROBERTDirector · 10% owner
ConversionCommon StockNon-derivative security · Code C5,482,309Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
NELSEN ROBERTDirector · 10% owner
ConversionCommon StockNon-derivative security · Code C3,294,900Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A22,6490Value: 0Currency not specifiedView ↗
Trade: ConversionCommon StockNon-derivative security · Code C610,759Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Nochur SaraDirector
Stock awardStock Option (Right to Buy)Derivative security · Code A22,6490Value: 0Currency not specifiedView ↗
Trade:
ORTH ANDREW C.President & CEO · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A77,9790Value: 0Currency not specifiedView ↗
Trade:
Philip Ron MDirector
Stock awardStock Option (Right to Buy)Derivative security · Code A22,6490Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A22,6490Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →